HJ-119
/ Chengdu Huajian Future Science and Technology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 26, 2025
HJ-119, a novel, highly selective, orally bioavailable small molecule KRASG12D inhibitor [WITHDRAWN]
(AACR 2025)
- "Our findings demonstrate the potent antitumor activity of HJ-119, and manifest a promisingly therapeutic prospect for patients suffering from KRASG12D mutant tumors."
Colorectal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor • KRAS
1 to 1
Of
1
Go to page
1